Century Therapeutics (NASDAQ: IPSC) released its Q4 earnings report on March 14, 2024, at 07:30 AM. Let’s delve into the key takeaways from the update:
– Earnings: Century Therapeutics fell short of the estimated earnings by -18.0%, with an EPS of $-0.65 compared to the expected $-0.55.
– Revenue: The company experienced a decrease in revenue of $253 thousand compared to the same period last year.
– Past Earnings Performance: In the previous quarter, Century Therapeutics missed EPS by $0.04, resulting in a 7.000000000000001% decline in the share price the following day.
Taking a closer look at Century Therapeutics’ historical performance:
– Q3 2023: EPS Estimate -0.51, EPS Actual -0.55, Revenue Estimate 1.16M, Revenue Actual 148K.
– Q2 2023: EPS Estimate -0.54, EPS Actual -0.56, Revenue Estimate 1.14M, Revenue Actual 99K.
– Q1 2023: EPS Estimate -0.52, EPS Actual -0.53, Revenue Estimate 1.31M, Revenue Actual 1.72M.
– Q4 2022: EPS Estimate -0.59, EPS Actual -0.55, Revenue Estimate 1.97M, Revenue Actual 521K.
For more details on Century Therapeutics’ earnings and reports, feel free to check out their earnings calendar.
IPSC Stock Price Update: March 14, 2024 – Analysis and Performance
On March 14, 2024, IPSC stock experienced a slight drop in price, opening at $4.84, which was $0.02 lower than its previous close. Throughout the day, the stock saw a decrease of $0.16, resulting in a 3.29% drop in value.
Despite this drop in price, IPSC is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time, even though it experienced a slight decline on this particular day.
IPSC Stock Performance Analysis: Net Income and EPS Decline in 2024
On March 14, 2024, investors were closely watching the stock performance of IPSC. According to data from CNN Money, IPSC reported a net income of -$130.93 million over the past year, representing a 36.64% decrease compared to the previous year. In the most recent quarter, the company’s net income stood at -$32.72 million, showing a 1.72% increase compared to the previous quarter. IPSC’s earnings per share (EPS) figures also painted a mixed picture of the company’s financial performance. The company reported an EPS of -$2.27 over the past year, marking a 30.13% decrease compared to the previous year. In the most recent quarter, IPSC’s EPS stood at -$0.55, showing a 2.05% increase compared to the previous quarter. On March 14, 2024, IPSC’s stock performance reflected these financial challenges. It is important for investors to closely monitor IPSC’s financial performance in the coming quarters to determine whether the company can reverse its downward trend in net income and EPS.
